Key points are not available for this paper at this time.
By law, dietary supplements whose ingredients were not sold in the United States before 1994 require demonstration of a “reasonable expectation of safety” — a currently unenforced requirement. Will the FDA's proposed new guidance in this area be adequate?
Pieter A. Cohen (Wed,) studied this question.